5.3 Mechanical Circulatory Support (LVAD, IABP, ECMO) & Heart Transplantation

5.3 Mechanical Circulatory Support (LVAD, IABP, ECMO) & Heart Transplantation

[!NOTE] ANCC Blueprint Context: Domain II (Planning and Implementation) evaluates the cardiovascular nurse's ability to manage advanced temporary and durable mechanical circulatory support (MCS) devices, calibrate and troubleshoot hemodynamic parameters, navigate life-threatening device complications, and care for orthotopic heart transplant recipients with denervated cardiac physiology.

Mechanical circulatory support (MCS) bridges critically ill patients to myocardial recovery, durable implantation, or heart transplantation. Navigating these technologies requires mastery of continuous-flow hemodynamics, counterpulsation mechanics, circuit oxygenation pathways, and denervated transplant physiology.

---

Intra-Aortic Balloon Pump (IABP) Counterpulsation

The Intra-Aortic Balloon Pump (IABP) is a temporary mechanical circulatory support catheter positioned in the descending thoracic aorta via the common femoral artery.

• Anatomical Catheter Location: The balloon tip resides 1 to 2 cm distal to the take-off of the left subclavian artery and proximal to the celiac and renal arteries. Proper placement is verified on chest radiography: the radiopaque tip must lie at the level of the carina or 2nd to 3rd intercostal space.
• Counterpulsation Physiological Cycle:
  1. Diastolic Inflation: The balloon inflates with helium gas immediately at the onset of diastole, synchronized to the dicrotic notch on the arterial pressure waveform (signaling aortic valve closure). Inflation displaces intra-aortic blood retrograde toward the aortic root, markedly augmenting coronary artery perfusion pressure and cerebral blood flow, while displacing blood anterograde to augment peripheral perfusion.
  2. Presystolic Deflation: The balloon deflates rapidly immediately prior to ventricular ejection, timed to isovolumetric contraction (coinciding with the R-wave on the ECG or the upslope of systole). Rapid deflation creates a localized vacuum that drops intra-aortic end-diastolic pressure, dramatically reducing left ventricular afterload, lowering myocardial wall stress, and reducing myocardial oxygen consumption ($MVO_2$).

Normal IABP Waveform:  Systole ──> [ Dicrotic Notch / INFLATION ] ──> Diastolic Augmentation ──> [ DEFLATION ] ──> Assisted Systole
                                      (Coronary Perfusion Spikes)                                 (Afterload Drops)

Waveform Timing Analysis & Timing Errors

Trigger Modes & Nursing Complications

• Trigger Modes: ECG (R-wave) is the primary, most reliable trigger. Arterial Pressure trigger serves as backup during electrical interference or tachyarrhythmias. Internal Mode (asynchronous cycling) is strictly contraindicated if the patient has any intrinsic rhythm; it is utilized exclusively during pulseless cardiac arrest / CPR.
• Complications:
  • Limb Ischemia: Caused by femoral artery obstruction or thrombosis by the 7–8 Fr catheter. Perform hourly neurovascular checks (dorsalis pedis and posterior tibial pulses, temperature, sensation, capillary refill).
  • Balloon Rupture: Aortic calcifications abrade the balloon material. Cardinal signs: gas leak alarms, sudden loss of augmentation, and brownish flecks or dried blood in the gas drive-line tubing. Emergency Action: Stop the pump immediately, clamp the tubing, and notify the physician for immediate catheter removal to prevent fatal helium gas embolism.
  • Catheter Migration: Migration cephalad occludes the left subclavian artery (loss of left radial pulse); migration caudad occludes the renal arteries (sudden drop in urine output, rising BUN/creatinine).
  • Platelet Destruction: Mechanical contact of platelets with the balloon membrane causes consumptive thrombocytopenia.

---

Continuous-Flow Left Ventricular Assist Devices (LVAD)

Contemporary Left Ventricular Assist Devices (such as the HeartMate 3) utilize continuous-flow centrifugal pumps with magnetic levitation (Full MagLev) to provide long-term circulatory support as Bridge to Transplant (BTT) or Destination Therapy (DT).

• Continuous-Flow Physiology: Blood is drawn continuously from the left ventricular apex through an inflow cannula and propelled into the ascending aorta via an outflow graft. Because ejection is continuous rather than pulsatile, patients often have diminished or absent peripheral pulses, an unmeasurable standard automated blood pressure, and a very narrow pulse pressure.
• Doppler Opening Pressure Measurement: Automated oscillometric cuffs fail due to non-pulsatile flow. Nurses must use a manual sphygmomanometer and Doppler ultrasound probe: place the probe over the brachial or radial artery to locate the continuous arterial "whooshing" flow signal, inflate the cuff until the sound ceases, and slowly deflate. The pressure at which the continuous flow signal returns is the Doppler opening pressure, which correlates directly with the Mean Arterial Pressure (MAP). The guideline-directed target MAP is 70 to 80 mmHg; MAP $>80\text{ to }85\text{ mmHg}$ increases pump afterload, reduces flow, and elevates stroke and aortic insufficiency risk.

Core Operating Parameters & Troubleshooting

[ LVAD Hemodynamic Profiles ]
  - Hypovolemia / Bleeding:    Flow DOWN ↓ | Power DOWN ↓ | PI DOWN ↓ | Doppler MAP DOWN ↓
  - Pump Thrombosis:           Flow DOWN ↓ | Power SPIKE ↑ | PI Variable | LDH Elevated (>2.5x)
  - RV Failure:                Flow DOWN ↓ | Power DOWN ↓ | PI DOWN ↓ | CVP Elevated (>16-20 mmHg)

High-Yield Post-Implant Complications

1. Right Ventricular (RV) Failure: Post-implant RV failure occurs in 20% to 40% of recipients. The LVAD unloads the left ventricle, augmenting systemic venous return; however, an ischemic, stunned, or diseased right ventricle cannot handle the increased preload. Manifestations: elevated CVP ($>16\text{ to }20\text{ mmHg}$), jugular venous distension, peripheral edema, ascites, accompanied by low LVAD flow, low power, and low PI (because the LV is underfilled). Managed with inotropes (milrinone, dobutamine), pulmonary vasodilators (inhaled epoprostenol, inhaled nitric oxide), and careful diuresis.
2. Pump Thrombosis: Thrombus deposition on the rotor or bearings. Manifestations: sudden power spikes ($>8\text{ to }10\text{ Watts}$), low-flow alarms, hemolysis evidenced by dark, tea-colored urine (hemoglobinuria), and a dramatic rise in serum Lactate Dehydrogenase (LDH $>2.5\text{ to }3\times$ upper limit of normal). Requires emergency heparinization, thrombolysis, or surgical pump exchange.
3. Gastrointestinal Bleeding: Occurs in 20% to 30% of patients due to a unique triad: (a) Acquired von Willebrand Syndrome (high mechanical shear stress of the continuous-flow rotor cleaves large von Willebrand factor multimers); (b) Arteriovenous Malformations (AVMs) in the bowel mucosa promoted by continuous, non-pulsatile perfusion; and (c) required therapeutic anticoagulation (warfarin target INR 2.0 to 3.0 plus aspirin).
4. Driveline Infections: The percutaneous lead exiting the abdominal wall is a prime portal for bacterial entry (Staphylococcus, Pseudomonas). Requires daily sterile dressing changes with chlorhexidine, use of driveline anchoring devices to prevent tissue traction, and aggressive antibiotics.

---

Extracorporeal Membrane Oxygenation: VA vs. VV ECMO

Extracorporeal Membrane Oxygenation (ECMO) provides temporary modified cardiopulmonary bypass at the bedside for refractory cardiac or respiratory failure.

Harlequin Syndrome (North-South / Differential Hypoxemia)

In peripheral VA-ECMO with femoral arterial cannulation, fully oxygenated blood from the circuit flows retrograde up the descending aorta. If the patient's native left ventricular function begins to recover while their lungs remain severely injured and poorly ventilated:

• The native LV ejects poorly oxygenated, hypoxic blood forward into the aortic root, ascending aorta, and aortic arch.
• This hypoxic blood preferentially perfuses the coronary arteries, brain, and right arm ("North").
• Simultaneously, well-oxygenated ECMO blood perfuses the lower body, kidneys, and extremities ("South").
• Mandatory Nursing Surveillance: To detect Harlequin syndrome, the nurse must maintain an arterial line and pulse oximeter on the RIGHT upper extremity (right radial artery / right hand). Hypoxemia in the right arm ($PaO_2 <60\text{ mmHg}, SpO_2 <90%$) signals cerebral and myocardial hypoxia. Corrected by improving ventilator settings, transitioning to V-A-V ECMO, or central cannulation.

---

Orthotopic Heart Transplantation: Denervated Heart Physiology

Heart transplantation is the definitive therapy for end-stage refractory Stage D heart failure (UNOS allocation Status 1 through 6).

Physiological Consequences of Cardiac Denervation

During orthotopic heart transplantation, the donor heart is completely transected from native sympathetic and parasympathetic (vagus) autonomic nerve fibers. This permanent surgical denervation alters baseline physiology:

1. Elevated Resting Heart Rate: The donor heart lacks parasympathetic vagal inhibitory restraint on the SA node. The baseline resting heart rate is consistently 90 to 110 beats/min.
2. Lack of Response to Atropine: Atropine is completely ineffective for treating bradycardia or AV block in a transplanted heart. Atropine acts by competitive antagonism of acetylcholine at muscarinic receptors on the vagus nerve; because the vagus nerve is severed, atropine has no target. Symptomatic bradycardia must be treated with direct-acting beta-agonists (isoproterenol, epinephrine) or transcutaneous/transvenous pacing.
3. Absence of Angina (Silent Ischemia): Afferent sensory fibers traversing cardiac nerves are severed. If the patient develops myocardial ischemia, infarction, or accelerated Cardiac Allograft Vasculopathy (CAV), they do not experience typical angina chest pain. Ischemia presents silently or manifests atypically as new-onset dyspnea, fatigue, nausea, diaphoresis, or sudden heart failure.
4. Blunted Response to Exercise: Cardiac acceleration during exercise does not occur via rapid neural reflexes. Instead, heart rate rises slowly in response to circulating catecholamines secreted by the adrenal medulla, and recovery is similarly delayed. Patients must perform extended warm-up and cool-down exercise periods.
5. Orthostatic Hypotension: Arterial baroreceptor reflex loops are blunted, predisposing to postural hypotension.

Immunosuppression Regimens & Rejection Surveillance

• Maintenance Triple-Drug Immunosuppression:
  • Calcineurin Inhibitor: Tacrolimus (Prograf; monitor 12-hour trough levels, target 8 to 12 ng/mL early, 5 to 8 ng/mL late; adverse effects include nephrotoxicity, hypertension, tremors, hyperglycemia) or Cyclosporine.
  • Antimetabolite: Mycophenolate Mofetil (CellCept; inhibits purine synthesis; adverse effects include bone marrow suppression, leukopenia, GI distress) or Azathioprine.
  • Corticosteroid: Prednisone (weaned over 6 to 12 months if stable).
• Surveillance for Allograft Rejection:
  • Endomyocardial Biopsy (EMB): Gold standard. Bioptome is inserted via the right internal jugular vein through the tricuspid valve to sample tissue from the RV septum. Evaluated for Acute Cellular Rejection (ISHLT grade 0R to 3R) and Antibody-Mediated Rejection (pAMR).
  • Noninvasive Testing: Donor-derived cell-free DNA (dd-cfDNA) and gene-expression profiling (AlloMap).
  • Clinical Manifestations of Acute Rejection: Low-grade fever, general malaise, unexplained weight gain, peripheral edema, new $S_3$ gallop, dysrhythmias (atrial flutter/fibrillation), hypotension, and a drop in LVEF on echocardiogram.